Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.74 HKD | -2.63% | -8.64% | -17.78% |
Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2021 | 660M 84.23M | Sales 2022 | 448M 57.22M | Capitalization | 506M 64.58M |
---|---|---|---|---|---|
Net income 2021 | -122M -15.58M | Net income 2022 | -120M -15.32M | EV / Sales 2021 | 1.14 x |
Net Debt 2021 | 436M 55.67M | Net Debt 2022 | 427M 54.57M | EV / Sales 2022 | 2.08 x |
P/E ratio 2021 |
-2.62
x | P/E ratio 2022 |
-4.2
x | Employees | 662 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 47.06% |
1 day | -2.63% | ||
1 week | -8.64% | ||
Current month | -10.84% | ||
1 month | -13.95% | ||
3 months | -13.95% | ||
6 months | -30.84% | ||
Current year | -17.78% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Hang Woon Ma
SAM | Sales & Marketing | - | - |
Pui Hung
HRO | Human Resources Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwok Wah Ho
BRD | Director/Board Member | 65 | 15-06-11 |
Lim Kin Leung
BRD | Director/Board Member | 70 | 15-06-11 |
Yu Ling Chan
CEO | Chief Executive Officer | 63 | 98-05-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 0.74 | -2.63% | 124 500 |
24-04-17 | 0.76 | +4.11% | 101,500 |
24-04-16 | 0.73 | -7.59% | 187,500 |
24-04-15 | 0.79 | 0.00% | 0 |
24-04-12 | 0.79 | -3.66% | 58,000 |
Delayed Quote Hong Kong S.E., April 18, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.78% | 38.34M | |
+40.29% | 6.02B | |
-15.73% | 4.55B | |
-9.40% | 3.13B | |
-1.60% | 3.07B | |
-1.23% | 2.57B | |
+34.89% | 1.82B | |
-11.37% | 1.63B | |
-5.02% | 1.57B | |
-13.21% | 1.54B |
- Stock Market
- Equities
- 1498 Stock